Dissecting antibody-mediated protection against SARS-CoV-2

被引:146
|
作者
Zohar, Tomer [1 ,2 ]
Alter, Galit [1 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[2] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA
关键词
CELLS;
D O I
10.1038/s41577-020-0359-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Understanding the properties and mechanisms by which antibodies provide protection is essential to defining immunity. Although neutralizing antibodies have been proposed as a potential key mechanism of protection against many viral pathogens, antibodies mediate additional immune functions that may have both protective and pathological consequences. Dissecting these properties against SARS-CoV-2 is likely necessary for defining metrics of immunity that will inform the design of vaccines and therapeutics and improve clinical management. Beyond neutralization, antibodies have immune-modulating functions that can be protective but, in some cases, can enhance pathology. Understanding these functions is critical for the development of safe vaccines and antibody therapies for COVID-19.
引用
下载
收藏
页码:392 / 394
页数:3
相关论文
共 50 条
  • [21] An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
    Chunyun Sun
    Hang Chi
    Fei Yuan
    Jing Li
    Ji Yang
    Aihua Zheng
    Fei Wang
    Lingling Sun
    Yanjing Zhang
    Ping Hu
    Lihua Jiao
    Yongqiang Deng
    Liangzhi Xie
    Science China Life Sciences, 2023, 66 (01) : 165 - 179
  • [22] An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2
    Sun, Chunyun
    Chi, Hang
    Yuan, Fei
    Li, Jing
    Yang, Ji
    Zheng, Aihua
    Wang, Fei
    Sun, Lingling
    Zhang, Yanjing
    Hu, Ping
    Jiao, Lihua
    Deng, Yongqiang
    Xie, Liangzhi
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (01) : 165 - 179
  • [23] Engineered Therapeutic Antibody Against SARS-CoV-2
    Monrat Chulanetra
    Current Clinical Microbiology Reports, 2023, 10 : 222 - 235
  • [24] Engineered Therapeutic Antibody Against SARS-CoV-2
    Chulanetra, Monrat
    CURRENT CLINICAL MICROBIOLOGY REPORTS, 2023, 10 (04) : 222 - 235
  • [25] Assessment of Protection against Reinfection with SARS-CoV-2
    Sharma, Abhishek
    Laishram, Guddi
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (09): : 75 - +
  • [26] Monoclonal antibody therapies against SARS-CoV-2
    Focosi, Daniele
    McConnell, Scott
    Casadevall, Arturo
    Cappello, Emiliano
    Valdiserra, Giulia
    Tuccori, Marco
    LANCET INFECTIOUS DISEASES, 2022, 22 (11): : E311 - E326
  • [27] Demands for Protection against SARS-CoV-2 in Prisons
    Keppler, Karlheinz
    Stoever, Heino
    SUCHT-ZEITSCHRIFT FUR WISSENSCHAFT UND PRAXIS, 2020, 66 (04): : 207 - 211
  • [28] SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity
    Manali, Maria
    Bissett, Laura A.
    Amat, Julien A. R.
    Logan, Nicola
    Scott, Sam
    Hughes, Ellen C.
    Harvey, William T.
    Orton, Richard
    Thomson, Emma C.
    Gunson, Rory N.
    Viana, Mafalda
    Willett, Brian
    Murcia, Pablo R.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 40 - 49
  • [29] Cross-reactive seasonal coronavirus antibody responses contribute to antibody-mediated effector functions against SARS-CoV-2 in individuals in Kenya.
    Ulusan, Sinem
    Bai, Shuangyi
    Murrell, Amelie
    Osoro, Eric
    Dawa, Jeanette
    Ngere, Isaac
    Langat, Robert
    Robinson, James
    Norton, Elizabeth
    Njenga, M. Kariuki
    Gunn, Bronwyn
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [30] Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
    Yuanyuan Qu
    Xueyan Zhang
    Meiyu Wang
    Lina Sun
    Yongzhong Jiang
    Cheng Li
    Wei Wu
    Zhen Chen
    Qiangling Yin
    Xiaolin Jiang
    Yang Liu
    Chuan Li
    Jiandong Li
    Tianlei Ying
    Dexin Li
    Faxian Zhan
    Youchun Wang
    Wuxiang Guan
    Shiwen Wang
    Mifang Liang
    Virologica Sinica, 2021, 36 (05) : 934 - 947